
Hartenberg's FutureLife bolts on Galway
FutureLife, a reproductive medicine business owned by CEE-focused investor Hartenberg Capital, has acquired fertility treatment provider Galway Fertility Clinic.
FutureLife acquired the business through its Irish subsidiary ReproMed, which the group bought in 2016. Financial details surrounding the transaction have not been disclosed.
Following the acquisition, the acquiring company aims to boost its presence across the Irish market.
The 2013-born GP founded FutureLife as a buy-and-build platform. To date, the business owns several companies operating in the genetic and diagnostic segments, including GynCentrum, Reprofit International, IVF Clinic, Iscare, Vidia-Diagnostika, Sanus, Dum Zdravi, Gennet, ReproMed and Codum. Prior to acquiring Galway, FutureLife had an enterprise value of €100m, the GP said.
Company
Headquartered in Galway, Ireland, the company was founded in 1994 as a spinout from Galway University Hospital. It manages fertility clinics focusing mainly on egg donation and genetic services.
People
Hartenberg Capital – Jozef Janov (managing partner).
Galway Fertility Clinic – Declan Egan (founder, director).
ReproMed – Declan Keane (CEO).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater